PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 2.62

(-6.43%)

Market Cap (In USD)

4.04 Million

Revenue (In USD)

21.27 Million

Net Income (In USD)

-98.06 Thousand

Avg. Volume

129.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.05-7.0
PE
2.43
EPS
1.08
Beta Value
1129406.6
ISIN
US6932981011
CUSIP
-
CIK
-
Shares
1545000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Distribution
CEO
Dr. Robert D. Holsey D.O., R.Ph.
Employee Count
-
Website
https://www.pdrx.com
Ipo Date
2003-10-15
Details
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company provides approximately 2,600 prepackaged medications; and creams, ointments, ophthalmics, otics, liquids, suspensions, etc. It also offers PD-Rx Net, a web-based application that tracks prescriptions filled at the point of care and print prescription labels for prescription that filled onsite; and manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a convenient handling package for physician dispensing customers. In addition, the company provides professional assistance by staffed pharmacists and physicians; and pharmaceutical sampling program design to reduce MCO's pharmaceutical costs, as well as allows medical professionals to offer pre-filled prescriptions to patients free of charge. It serves physicians, pharmacies, and medical clinics. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma.